Preparation and anti-cancer evaluation of promiximab-MMAE, an anti-CD56 antibody drug conjugate, in small cell lung cancer cell line xenograft models. [electronic resource]
Producer: 20191125Description: 905-912 p. digitalISSN:- 1029-2330
- Animals
- CD56 Antigen -- genetics
- Cell Line, Tumor
- Chromatography, Liquid -- methods
- Gene Expression Profiling
- Humans
- Immunoconjugates -- pharmacology
- Lung Neoplasms -- immunology
- Mice
- Oligopeptides -- pharmacology
- Small Cell Lung Carcinoma -- immunology
- Tandem Mass Spectrometry -- methods
- Xenograft Model Antitumor Assays
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.